Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
182,302
-
Shares change
-
+157,286
-
Total reported value, excl. options
-
$179,171
-
Value change
-
+$101,129
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$0.9848
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q2 2024
16 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q2 2024.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 182,302 shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (130,000 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,260 shares), GEODE CAPITAL MANAGEMENT, LLC (14,610 shares), VANGUARD GROUP INC (12,598 shares), Tower Research Capital LLC (TRC) (6,904 shares), UBS Group AG (1,549 shares), CoreCap Advisors, LLC (200 shares), OSAIC HOLDINGS, INC. (80 shares), Federation des caisses Desjardins du Quebec (37 shares), and American Capital Advisory, LLC (31 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.